AOD-9604 does not influence the WADA hGH isoform immunoassay
It is a combination of a GLP-1 agonist and an amylin agonist, explains Richard Siegel, MD, co-director of the Diabetes and Lipid Center at Tufts Medical Center and endocrinologist at Tufts Medicine Weight & Wellness Center Stoneham
Less commonly, people taking GLP-1 medications can experience problems with the pancreas, stomach, intestines, gallbladder, or kidneys
Therefore, all chemicals included here were also assessed with respect to their potential to deliver false-positive results in screening assays due to non-specific reactive chemistry interference, using the pan assay interference compounds (PAINS) remover tool (version Demo 0.99) (235)
Patients should be committed to healthy lifestyle changes like a reduced-calorie diet and exercise so they can successfully lose weight and maintain their results
It acknowledges that effective treatment must go beyond surface-level advice and address core biological resistance